Clovis Oncology to Highlight Rubraca rucaparib Data from PostHoc ARIEL3 Analyses at SGO 2019 Congress

Clovis Oncology to Highlight Rubraca (rucaparib) Data from Post-Hoc ARIEL3 Analyses at SGO 2019 Congress

Exploratory analyses of ARIEL3 Rubraca data in recurrent ovarian cancer presented in oral plenary and poster sessions Maintenance treatment with Rubraca improved median progression-free survival (...

More From BioPortfolio on "Clovis Oncology to Highlight Rubraca (rucaparib) Data from Post-Hoc ARIEL3 Analyses at SGO 2019 Congress"